Suchen nach…

• Controlled release of therapeutical agents from polymer brush coatings by employing reversible polymer condensation using ionic cross-linkers

  B79086

  Controlled release of therapeutical agents from polymer brush coatings by employing reversible polymer condensation using ionic cross-linkers

  • Surface coat with drug encapsulation for medical implants
  • Triggered drug release by contact with physiological salt concentrations
  • Quickly achieve therapeutic levels at actual site of inflammation
• Nanoparticles for the targeted treatment of neovascular ocular diseases

  B79130

  Nanoparticles for the targeted treatment of neovascular ocular diseases

  • systemic therapy instead of intravitreal antibody injections
  • a single systemic injection cured retinopathy of prematurity in mouse model
  • causal treatment of all neovascular ocular diseases
• Virus-mimetic nanoparticles for diabetic nephropathy

  B79122

  Virus-mimetic nanoparticles for diabetic nephropathy

  • Specific drug delivery via nanoparticles
  • Virus like targeting in a two-stage process
  • Dose reduction compared to free drug
• Active emulgels for controlled zero-order drug release

  B79089

  Active emulgels for controlled zero-order drug release

  • Platform for zero-order (linear) drug-release
  • Constant, tunable release of hydrophobic drugs
  • 3 components, economical and straightforward
• Hydrogels: Injectable Depot-Systems

  B76151

  Hydrogels: Injectable Depot-Systems

  • Gelatinize by a dual mechanism based on Diels-Alder reaction and physical crosslinking
  • Stability and stiffness can be adjusted to therapeutic need
  • Hydrogels are stable, in situ forming, non-toxic and particularly suitable for controlled drug release

5 von 131 Tech Offers